Clinical Trial

Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects

Name: Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects — clinical trial record (NCT07421739)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.

Trial Details

NCT Number	NCT07421739
Lead Sponsor	Aura Biosciences Collaborators: Vitaccess Ltd
Conditions	Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma
Enrollment	15 participants
Start Date	2025-11-12
Primary Completion	2028-08-15 (estimated)
Study Completion	2028-08-15 (estimated)
Updated on ClinicalTrials.gov	2026-02-19